NKGEN Biotech

NKGEN Biotech

  • Founded: 2017
  • Location: Santa Ana, CA
  • Employee range: 50 - 200
  • Clinical stage: Clin1
  • Therapy area: Neurodegenerative Disease
  • Drug types: ONC, NEU
  • Lead product: SNK01
  • Product link: https://nkgenbiotech.com/pipeline/
  • Investors: SPAC planned Apr 2023



job board

Short description:

Autologous and allogenic Natural Killer cell therapy

Drug notes:

Also Clin1 solid tumors; SNK02 Clin0 undisclosed oncology targets; CAR-SNK02 RD/Clin0 HER2+ solid tumors

Long description:

Contact us to add description.


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com